The combination of atenolol with diltiazem has been shown to be useful in the treatment of patients with coronary artery disease. Eighteen patients with proven coronary artery disease, stable angina, and no previous myocardial in farction were studied before and after treatment with atenolol (100 mg/day) (9 patients) or diltiazem (180 mg/day) (9 patients). Ischemic threshold at stress test, pressure-rate product at ischemic threshold, direct oxygen consumption at ischemic threshold, and exercise ejection fraction were determined.
There was a slight increase in the duration of exercise, maximal oxygen con sumption, and ischemic threshold after treatment with each drug. Double prod uct at ischemic threshold decreased from 20.9 to 19.8 (p = NS) with atenolol but increased from 20.1 to 21.9 (p=NS) with diltiazem. Conversely oxygen con sumption at ischemic threshold increased with atenolol to nearly significant val ues from 17.2 to 23.6 (p = 0.067) but not with diltiazem (16.2 to 22.3; p = 0.16) .
Before treatment, exercise ejection fraction increased less than 10% or de creased from its resting values in all patients but 1 with atenolol and 1 with diltiazem, but exercise ejection fraction increased significantly after treatment with atenolol (60.6 to 67.5; p=0.02) but not with diltiazem. This improvement was due to a significant reduction in end systolic volume (103.8 to 78.6; p=0.019), despite a similar increase in heart rate and blood pressure in all patients.
There was a trend to increase ischemic threshold with both drugs that could have been produced by: (1) atenolol, by increasing oxygen consumption at the ischemic threshold, which suggests an improvement in ventricular perform ance; (2) diltiazem, by increasing double product at the ischemic threshold, which reflects an increase in myocardial oxygen consumption at the ischemic threshold and suggests a parallel improvement in myocardial flow. Atenolol produces a significant increase in exercise ejection fraction owing to a reduction in end systolic volume. This finding suggests a protective effect of atenolol in exercise-induced ischemia and agrees with the trends observed in stress tests.
Get full access to this article
View all access options for this article.
References
1.
Uusitalo A., Arstila M., Bae AE, et al: Metoprolol, nifedipine, and the combination in stable effort angina pectoris. Am J Cardiol57:733-737, 1986.
2.
Hung J., Lamb I., Connolly S., et al: The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: A double-blind, randomized and placebo controlled study. Circulation68:560-567, 1983.
3.
Braun S., Terdiman R., Berenfeld D., et al: Clinical and hemodynamic effects of combined propranolol and nifedipine therapy versus propranolol alone in patients with angina pectoris . Am Heart J109:478-485, 1985.
4.
Lynch P., Dargie H., Krikler S., et al: Objective assessment of antianginal treatment: A double-blind comparison of propranolol, nifedipine and their combination. Br Med J281:184-187, 1980.
5.
Subramanian B., Bowles MJ, Daves AB, et al: Combined therapy with verapamil and propranolol in chronic stable angina. Am J Cardiol49:125-132, 1982.
6.
Leon MB, Rosing DR, Bonow RO, et al: Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. Am J Cardiol48:131-139, 1981.
7.
Kostuk WJ, Pflugfelder P.: Comparative effects of calcium entry blocking drugs, beta blocking drugs, and their combination in patients with chronic stable angina. Circulation75(Suppl V):V114-V121, 1987.
8.
Subramanian B., Bowles MJ, Davies AB, et al: Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind, placebo controlled comparison of verapamil and propranolol. Am J Cardiol50:1159-1163, 1982.
9.
Johnston DL, Lesoway R., Humen DP, et al: Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: A placebo controlled, double-blind, randomized, crossover study. Am J Cardiol55:680-687, 1985.
10.
Boda W., Bough E., Reichman M., et al: Beneficial effects of high dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates, a randomized, double-blind, placebo controlled, crossover study. Circulation71:1197-1205, 1985.
11.
Strauss W., Parisi A.: Superiority of combined diltiazem and propranolol therapy for angina pectoris . Circulation71:951-957, 1985.
12.
Pfisterer M. , Glaus L., Birkaut F.: Comparative effects of nitroglycerin, nifedipine and metoprolol on ventricular function in patients with one-vessel coronary disease. Circulation67:291-301, 1983.
13.
Packer M., Meller J., Medina N., et al: Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation65:660-668, 1982.
14.
Hossack KF, Pool PE, Steele P., et al: Efficacy of diltiazem in angina on effort; a multicentric trial . Am J Cardiol49:567-572, 1982.
15.
Campeau L.: Grading of angina pectoris. Circulation54:522, 1976.
16.
Marsh JD, Green LH, Wynne J., et al: Left ventricular end-systolic pressure-dimension and stress length relations in normal human subjects. Am J Cardiol44:1311-1317, 1979.
17.
Merino A., Alegría E., Castelló R. et al: Left ventricular force length relations in normal healthy subjects . Eur Heart J8(Suppl 2):56, 1987.
18.
Bourassa MG, Cote P., Theroux P., et al: Hemodynamics and coronary blood flow following diltiazem administration in anesthetized dogs in humans. Chest78(Suppl):224-230, 1980.
19.
Millard R., Lathrop DA, Grupp G., et al: Differential cardiovascular effects of calcium channel blocking agents: Potential mechanisms. Am J Cardiol49:499-506, 1984.
20.
Da Luz PL, Monteiro De Barros LF, Leite JJ, et al: Effect of verapamil on regional coronary and myocardial perfusion during acute coronary occlusion. Am J Cardiol45:269-275, 1980.
21.
Matsuzaki M. , Pattriti J., Tajini J., et al: Effect of beta blockade on regional myocardial flow and function during exercise. Am J Physiol16:H52-H60, 1984.
22.
Matsuzaki M. , Gallagher KP, Pattriti J., et al: Effects of a calcium entry blocker (diltiazem) on regional myocardial flow and function during exercise in conscious dogs. Circulation69:801-814, 1984.
23.
Bache RJ, Tockman BA: Effect of nitroglycerin and nifedipine on subendocardial perfusion in the presence of a flow limiting coronary stenosis in the awake dog. Circ Res50:678-687, 1982.
24.
Matsuzaki M. , Guth B., Tajini T., et al: Effect of the combination of diltiazem and atenolol on exercise induced myocardial ischemia in conscious dogs. Circulation72:233-243, 1985.
